Immunovant EPS misses by $0.08
- BySeeking Alpha-
Immunovant (IMVT): Q2 GAAP EPS of -$0.35 misses by $0.08.Cash of $599MShares -3.1% PM.Press Release
Symbol | Exchange | Currency |
|---|
Immunovant (IMVT): Q2 GAAP EPS of -$0.35 misses by $0.08.Cash of $599MShares -3.1% PM.Press Release
Immunovant (IMVT) appoints Renee Barnett, as CFO, effective October 4, 2021.Ms
Clinical-stage biopharmaceutical company Immunovant (IMVT) has reported a net loss of $0.31 for the second quarter of 2021, which is in line with the analysts’ expectations. Also,...
Immunovant (NASDAQ:IMVT), Inc. IMVT reported a net loss of 35 cents per share in the second quarter of fiscal 2022 (ended Sep 30, 2021), wider than the Zacks Consensus Estimate of...
Dan Laboe here, Editor of the Headline Trader portfolio. I am covering for the acclaimed Jim who will be back in action tomorrow. The market is growing increasingly cautious as...
Last year was a remarkable period for companies to go public via special purpose acquisition companies (SPACs). In 2020, in fact, there were 248 completed deals in the US. In 2019,...
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Neutral | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 162.53 | 162.71 | 157.80 | -2.24 | -1.36% | 74.36M | NASDAQ | |||
| 311.13 | 314.59 | 307.20 | +0.53 | +0.17% | 12.39M | NASDAQ | |||
| 2,866.00 | 2,866.00 | 2,805.00 | +45.0 | +1.59% | 672.88K | NASDAQ | |||
| 14.52 | 14.72 | 14.10 | -0.06 | -0.41% | 503.02K | NASDAQ | |||
| 12.88 | 12.96 | 12.50 | +0.63 | +5.18% | 19.32M | NYSE | |||
| 73.83 | 73.83 | 70.32 | +3.52 | +5.01% | 474.86K | NYSE | |||
| 323.30 | 323.79 | 310.33 | +8.95 | +2.85% | 25.45M | NASDAQ | |||
| 53.34 | 55.08 | 53.33 | -1.34 | -2.45% | 18.94M | NYSE | |||
| 296.61 | 318.44 | 291.03 | -14.00 | -4.51% | 10.13M | NASDAQ | |||
| 3,454.10 | 3,491.00 | 3,426.98 | +10.38 | +0.30% | 1.60M | NASDAQ | |||
| 123.90 | 125.00 | 120.93 | +1.41 | +1.15% | 12.05M | NYSE | |||
| 45.29 | 45.55 | 41.74 | +5.08 | +12.63% | 12.32M | NYSE | |||
| 29.89 | 31.20 | 27.02 | +1.32 | +4.62% | 37.29M | NYSE | |||
| 163.22 | 163.22 | 158.83 | +5.33 | +3.38% | 4.56M | NYSE | |||
| 82.62 | 83.59 | 81.36 | -2.53 | -2.97% | 12.92M | NASDAQ |